13-04-2025 22:09 via medpagetoday.com

Pridopidine Shows Promise in Subgroup of Huntington's Patients

(MedPage Today) -- SAN DIEGO--Treatment with investigational pridopidine seemed to offer benefits for certain patients with Huntington's disease, according to subgroup analysis of the PROOF-HD trial.
Those improvements were seen in terms of...
Read more »

Medical Industry news



Study Pinpoints Barriers to Kids Receiving Living-Donor Kidney Transplants
Docs Decry Optum's Tactics for Collecting Loan Repayments From Change Cyberattack
Emergency Care for Cannabis Use Tied to Higher Dementia Risk
Months After CEO's Killing, Intruder Arrested Near UnitedHealthcare's Headquarters
A Reported Intruder Is Arrested Near UnitedHealthcare Headquarters
Will Memoli Be the Next NIAID Director?
Another Push for Upfront Ezetimibe-Statin Combo Soon After MI
CT Scans in a Single Year Could Result in 100,000 Future Cancers in the U.S.
Impending Supreme Court Decision Could Upend Planned Parenthood Funding
Faster, More Frequent Proteinuria Reduction With Sparsentan in FSGS
Sharing in Shared Medical Decision-Making
Tolebrutinib Benefits Non-Relapsing Secondary Progressive Multiple Sclerosis
Screening for Depression and Anxiety in Multiple Sclerosis
Measles Exploded in Texas After Stagnant Vaccine Funding
Desktop versie